Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;38(5):1996-2006.
doi: 10.1007/s10753-015-0180-7.

Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens

Affiliations

Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens

Janka Bábíčková et al. Inflammation. 2015 Oct.

Abstract

Sex differences have been found in the incidence and progression of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The reported differences in observational studies are controversial, and the effects of sex hormones on the pathogenesis of IBD are not clear. The aim of this study was to analyze sex differences in the progression of experimentally induced colitis. Experimental colitis was induced in adult mice by adding 2% dextran sodium sulfate (DSS) into drinking water. Male and female mice were used as intact, gonadectomized, and supplemented with either estradiol or testosterone. In comparison to males, female mice with induced colitis had significantly longer colon (p < 0.05), lower decrease in body weight (p < 0.001), and lower stool consistency score (p < 0.05). Histopathological analysis showed less inflammatory infiltrates (p < 0.001) and crypt damage (p < 0.001) in female mice. Female mice with colitis had also lower concentration of TNF-α in colon homogenates (p < 0.01). Supplementation with estradiol in ovariectomized mice ameliorated the severity of colitis. Female mice are partially protected against chemically induced colitis. This protection seems to be mediated by estradiol.

PubMed Disclaimer

References

    1. Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003 - PubMed
    1. Horm Res Paediatr. 2011;75(1):8-13 - PubMed
    1. Eur J Gastroenterol Hepatol. 2006 Jun;18(6):601-6 - PubMed
    1. Dig Liver Dis. 2003 Feb;35(2):99-103 - PubMed
    1. Clin Exp Immunol. 1998 Dec;114(3):385-91 - PubMed

Publication types

LinkOut - more resources